Danique Giesen

Search results

• 2022

  ⁸⁹Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancer

  Kok, I. C., Hooiveld, J. A., van de Donk, P. P., Giesen, D., van der Veen, E. L., Lub-de Hooge, M. N., Brouwers, A. H., Hiltermann, T. J. N., van der Wekken, A. J., Hijmering-Kappelle, L. B. M., Timens, W., Elias, S. G., Hospers, G. A. P., Groen, H. J. M., Uyterlinde, W., van der Hiel, B., Haanen, J. B., de Groot, D. J. A., Jalving, M. & de Vries, E. G. E., Jan-2022, In: Annals of Oncology. 33, 1, p. 80-88 9 p.

  Research output: Contribution to journal › Article › Academic › peer-review
  12 Downloads (Pure)
• 2021

  First-in-human study of the biodistribution and pharmacokinetics of ⁸⁹Zr-CX-072, a novel immunopet tracer based on an anti–PD-L1 probody

  de Ruijter, L. K., Hooiveld-Noeken, J. S., Giesen, D., Lub-De Hooge, M. N., Kok, I. C., Brouwers, A. H., Elias, S. G., Nguyen, M. T. L., Lu, H., Gietema, J. A., Jalving, M., de Groot, D. J. A., Vasiljeva, O. & de Vries, E. G. E., 1-Oct-2021, In: Clinical Cancer Research. 27, 19, p. 5325-5333 9 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access

  File
• 2020

  Moleculaire beeldvorming met 89Zr-immunoPET in translationele studies op het gebied van immuuntherapie

  Giesen, D., Lub-de Hooge, M. & Brouwers, A., Dec-2020, In: Tijdschrift voor Nucleaire Geneeskunde. 43, 4, p. 2576-2582

  Research output: Contribution to journal › Article › Professional

• Preclinical PET imaging of bispecific antibody ERY974 targeting CD3 and glypican 3 reveals that tumor uptake correlates to T cell infiltrate

  Waaijer, S. J., Giesen, D., Ishiguro, T., Sano, Y., Sugaya, N., Schröder, C. P., de Vries, E. G. & Lub-de Hooge, M. N., 2020, In: Journal for immunotherapy of cancer. 8, 1, 10 p., e000548.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access

  File
  4 Citations (Scopus)

  67 Downloads (Pure)

• Probody therapeutic design of 89Zr-CX-072 promotes accumulation in PD-L1 expressing tumors compared to normal murine lymphoid tissue

  Giesen, D., Broer, L. N., Lub-de Hooge, M. N., Popova, I., Howng, B., Nguyen, M., Vasiljeva, O., de Vries, E. G. E. & Pool, M., 1-Aug-2020, In: Clinical Cancer Research. 26, 15, p. 3999-4009 11 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access

  File
  10 Citations (Scopus)

  13 Downloads (Pure)

• Zr-89-pembrolizumab biodistribution is influenced by PD-1-mediated uptake in lymphoid organs

  van der Veen, E. L., Giesen, D., Pot-de Jong, L., Jorritsma-Smit, A., De Vries, E. G. E. & Lub-de Hooge, M. N., 5-Oct-2020, In: Journal for immunotherapy of cancer. 8, 2, 12 p., 000938.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access

  File
  7 Citations (Scopus)

  25 Downloads (Pure)
• 2017

  (89)Zr-Onartuzumab PET imaging of c-MET receptor dynamics

  Pool, M., van Scheltinga, A. G. T. T., Kol, A., Giesen, D., de Vries, E. G. E. & Lub-de Hooge, M. N., Aug-2017, In: European Journal of Nuclear Medicine and Molecular Imaging. 44, 8, p. 1328-1336 9 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access

  File
  18 Citations (Scopus)

  426 Downloads (Pure)